Exhibit 99.1

 

 

Contact:  Robert S. Breuil

 

 

 

(650) 864-7431

 

 

AEROGEN, INC. REPORTS THIRD QUARTER 2004 FINANCIAL RESULTS

 

Mountain View, CA, October 28, 2004

– Aerogen, Inc. (Nasdaq: AEGN) today announced financial results for the three months and nine months ended September 30, 2004.  The net loss attributable to common stockholders for the three months ended September 30, 2004 was $4.6 million, or $0.96 per share, compared with a net loss of $4.4 million, or $1.06 per share, for the same period in 2003.  The net loss attributable to common stockholders for the nine months ended September 30, 2004 was $25.6 million, or $5.47 per share, compared with $12.3 million, or $3.00 per share, for the same period in 2003.

 

Aerogen’s cash balance as of September 30, 2004 was $20.3 million.

 

The results for the nine months ended September 30, 2004 include a charge of $12.4 million, or $2.65 per share, reflecting a deemed dividend imputed from the difference between the value of the Company’s common stock and the accounting value of the Company’s Series A-1 Convertible Preferred Stock that was issued during the first half of 2004.  There were no deemed dividends in 2003.  As deemed dividends are only incurred upon the issuance of certain securities, and the Company completed its planned issuance of Series A-1 Convertible Preferred Stock in May 2004, there will be no further charges for deemed dividends related to the Series A-1 Convertible Preferred Stock financing.

 

The terms of the Series A-1 Convertible Preferred Stock provide for a dividend, at the rate of 6% per year, to be paid quarterly in cash or Aerogen common stock, at the Company’s election, to each holder of Series A-1 Convertible Preferred Stock.  During the three and nine months ended September 30, 2004, the Company elected to pay this dividend in Aerogen common stock, resulting in charges related to ordinary dividends of $0.5 million, or $0.11 per share, and $0.9 million, or $0.20 per share, respectively.  The Company did not pay any such dividends during 2003.

 

Revenues for the three months ended September 30, 2004 were $1.2 million, compared with $0.5 million for the same period in 2003.  Revenues for the nine months ended September 30, 2004 were $4.0 million compared with $3.2 million for the same period in 2003.  The increase in revenues for the three-month period ending September 30, 2004, as compared with the same period in 2003, primarily resulted from an increase in product sales of the Aeroneb Pro, in addition to revenues recognized under our distribution agreement with Evo Medical Solutions (“Evo”) related to the continued amortization of up-front payments, and royalty revenues associated with Evo’s sales of the Aeroneb® Go Nebulizer.  The increase in revenues for the nine-month period ending September 30, 2004, as compared with the same period in 2003, was primarily due to higher royalty revenues associated with our distribution partner’s sales of the Aeroneb Go and amortization of up-front payments, in addition to the higher product sales of the Aeroneb Pro.

 

Cost of products sold for the three months ended September 30, 2004 was $0.8 million, compared with $0.2 million for the same period in 2003.  Cost of products sold for the nine

 

-more-


The following information was filed by Aerogen Inc on Thursday, October 28, 2004 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Aerogen Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aerogen Inc.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account